WeChat Mini Program
Old Version Features

EASIX-guided Risk Stratification for Complications and Outcome after CAR T-cell Therapy with Ide-Cel in Relapsed/refractory Multiple Myeloma

Jan H. Frenking,Xiang Zhou, Vivien Wagner,Thomas Hielscher,Joseph Kauer,Elias K. Mai,Mirco J. Friedrich,Christian S. Michel,Marina Hajiyianni,Iris Breitkreutz,Patrick Costello,Omar Nadeem,Niels Weinhold,Hartmut Goldschmidt,Anita Schmitt,Thomas Luft,Michael Schmitt,Carsten Mueller-Tidow,Max Topp,Hermann Einsele,Peter Dreger,Nikhil C. Munshi,Adam S. Sperling,Leo Rasche,Sandra Sauer,Marc S. Raab

JOURNAL FOR IMMUNOTHERAPY OF CANCER（2024）

Cited 1|Views4
Key words
chimeric antigen receptor - CAR,multiple myeloma,immunotherapy,cytopenia,treatment related adverse event - trAE
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined